GlassScriptPhysician profile
Glen A Johnson
NPI 1265583751
$364.74
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $54.50 · 2021: $13.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $106.57 | 2019 | |
| Kaleo, INC. | $76.62 | 2019 | |
| Amgen INC. | $53.32 | 2020-2021 | |
| Pernix Therapeutics Holdings, INC. | $28.23 | 2019 | |
| Pacira Therapeutics, INC. | $27.54 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.22 | 2019 | |
| Redhill Biopharma INC. | $15.07 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.02 | 2019 | |
| Nevro Corp. | $12.45 | 2019 | |
| Boston Scientific Corporation | $11.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.